Get started
Author

Lea H. Kunze

Observed names: Kunze, Lea, Kunze, Lea H., Kunze, Lea Helena, L H Kunze, L. H. Kunze, L. Kunze, L.H. Kunze, Lea H Kunze, Lea Helena Kunze, Lea Kunze
Observed institutions: German Center for Neurodegenerative Diseases, TUM Klinikum, LMU Klinikum, Klinik und Poliklinik für Nuklearmedizin, Munich Cluster for Systems Neurology, German Center for Neurodegenerative Diseases (DZNE) Dresden, Technical University of Munich, Ludwig-Maximilians-Universität München
ORCID: 0000-0003-4669-2113
Observed ORCID: 0000-0003-4669-2113
OpenAlex ID: A5070475227
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
2023 · Bettina van Lengerich, Lihong Zhan, et al. · Nature Neuroscience · 229
PDF
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia
2022 · Dan Xia, Steve Lianoglou, et al. · Molecular Neurodegeneration · 122
PDF
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies
2024 · Monireh Shojaei, Rebecca Schaefer, et al. · Theranostics · 33
PDF
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
2023 · Laura M. Bartos, Sabrina V. Kirchleitner, et al. · Science Advances · 25
PDF
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies
2024 · Luna Slemann, Johannes Gnörich, et al. · Acta Neuropathologica · 20
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis
2025 · Emily M. Ullrich Gavilanes, Laura M. Bartos, et al. · Science Translational Medicine · 10
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
2024 · Laura M Bartos, Stefanie Quach, et al. · Clinical Cancer Research · 9
PDF
Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice
2023 · Lea Helena Kunze, François Ruch, et al. · International Journal of Molecular Sciences · 9
PDF
18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model
2022 · Laura M. Bartos, Sabrina V. Kirchleitner, et al. · Frontiers in Medicine · 9
PDF
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging
2023 · Letizia Vogler, Anna Ballweg, et al. · NeuroImage Clinical · 8
An Exploratory Analysis of Differential Tear Fluid miRNAs in Patients with Parkinson’s Disease and Atypical Parkinsonian Syndromes
2025 · Antonia F. Demleitner, Lucas Caldi Gomes, et al. · Molecular Neurobiology · 6
PDF
Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging
2023 · Giovanna Palumbo, Lea Helena Kunze, et al. · Animals · 5
PDF
Design, Synthesis and Preclinical Evaluation of a Brain-Permeable PET Tracer for P2Y12 Receptor Imaging in the Brain
2025 · Emanuel Joseph, Lea H. Kunze, et al. · Journal of Medicinal Chemistry · 4
Image-Derived Blood Normalization of Antibody-Based TREM2 PET in Mouse Models of Amyloidosis and Myocardial Infarction
2025 · Rebecca Schaefer, Lea H. Kunze, et al. · Journal of Nuclear Medicine · 4
PDF
Neuronal and oligodendroglial but not astroglial tau translates to in vivo tau-PET signals in primary tauopathies
2024 · Luna Slemann, Johannes Gnörich, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
Fibrillar amyloidosis and synaptic vesicle protein expression progress jointly in the cortex of a mouse model with β-amyloid pathology
2025 · L.H. Kunze, G. Palumbo, et al. · NeuroImage · 3
Design, Synthesis and Preclinical Evaluation of a Novel PET Tracer for P2Y12R Imaging in the Brain
2025 · Emanuel Joseph, Lea H. Kunze, et al. · ChemRxiv · 1
PDF
Allocation of TSPO-PET signals to cellular and extracellular compartments in dependence of blood-brain barrier disruption in experimental glioblastoma
2026 · Leonie Hoermann, Fatma Burcu Seker, et al. · European Journal of Nuclear Medicine and Molecular Imaging
PDF
Whole-body TSPO-PET reveals stage-dependent disruption of systemic immune organ interactions in glioblastoma
2026 · Gloria Mueller, Artem Zatcepin, et al. · European Journal of Nuclear Medicine and Molecular Imaging
PDF
Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer’s Disease Model
2026 · Karin Wind-Mark, Lea H. Kunze, et al. · International Journal of Molecular Sciences
Dynamic regional divergence of SV2A expression in a mouse model of primary tauopathy: A longitudinal multi-tracer PET study
2026 · Yunlei Li, Artem Zatcepin, et al. · NeuroImage
Translationales Potenzial von MAO-B als Biomarker im Glioblastom
2026 · J Thevis, L Bartos, et al. · Nuklearmedizin - NuclearMedicine
TSPO-PET-basierter Nachweis einer myeloiden Immunaktivierung im frontopolaren Schädelknochen bei Patienten mit Glioblastom
2026 · Z I Kolabas, L Bartos, et al. · Nuklearmedizin - NuclearMedicine
Assessment of early-phase [ 18 F]florbetaben images as a proxy for brain metabolism in mouse models of Alzheimer’s disease
2026 · Robin Gröger, Amelie L Englert, et al. · Journal of Cerebral Blood Flow & Metabolism
Transport vehicle–mediated TREM2 PET maps myeloid cells in the glioblastoma microenvironment
2026 · Matthias Brendel, Laura Bartos, et al. · Research Square
PDF
Works count: 72
Citation count: 500
H-index: 9
I10-index: 6
Year
Topic
Type